Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapeutics    symbols : Agrx    save search

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: -10.0% H: 21.62% C: 2.1%

year update therapeutics financial results
Agile Therapeutics Announces Delisting from Nasdaq
Published: 2024-03-25 (Crawled : 21:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: -60.23% H: 41.96% C: 39.46%

nasdaq therapeutics
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024Live Conference Call and Webcast at 8:30 a.m. ET
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: -3.28%

conference report business year update therapeutics financial results
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: -3.28%

report business year update therapeutics financial results
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 9.33% C: 9.14%

report business year update therapeutics financial results
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 13.85% H: 0.0% C: -14.94%

business therapeutics
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
Published: 2024-02-22 (Crawled : 14:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 32.03% H: 0.0% C: -27.68%

million therapeutics
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
Published: 2024-02-15 (Crawled : 22:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 2.26% H: 1.6% C: -4.0%

nasdaq granted update extension therapeutics
Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -6.85%

update care contraceptive therapeutics
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 1.01% H: 11.56% C: 2.5%

update therapeutics financial results
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 1.09% H: 0.0% C: -2.16%

report business update therapeutics financial results
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-10-04 (Crawled : 20:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 3.97% C: -1.0%

nasdaq grant therapeutics financial
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 3.19% H: 0.61% C: -5.02%

conference global therapeutics
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-09 (Crawled : 12:00) - ir.agiletherapeutics.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 2.32% H: 0.38% C: -13.2%

update therapeutics financial results
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Published: 2023-07-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: -3.11% H: 1.43% C: 0.0%

report business therapeutics financial results
Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Published: 2023-07-18 (Crawled : 15:00) - biospace.com/
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 6.02% H: 4.1% C: -2.21%

control women therapeutics
H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
Published: 2023-07-05 (Crawled : 14:00) - biospace.com/
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 3.96% H: 7.94% C: 5.4%

control growing therapeutics
Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 3.91% H: 0.0% C: -6.51%

twirla therapeutics
Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services
Published: 2023-06-23 (Crawled : 16:00) - ir.agiletherapeutics.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.48% C: -2.09%

services family contraception therapeutics
Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health
Published: 2023-06-15 (Crawled : 20:00) - ir.agiletherapeutics.com
AGRX | $0.3856 0.0% 120K twitter stocktwits trandingview |
Health Technology
| | O: -6.77% H: 11.55% C: 7.59%

twirla health therapeutics
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.